STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. (16th September 2021) - Gerthofer, Valeria; Scheiter, Alexander; Lüke, Florian; Keil, Felix; Utpatel, Kirsten; Pöhmerer, Laura-Maria-Giovanna; Seitz, Johannes; Niessen, Christoph; Ignatov, Atanas; Dietmaier, Wolfgang; Calvisi, Diego F.; Evert, Matthias; et al.